Appetite & fullness support
Injectable tirzepatide acts on GIP and GLP-1 pathways involved in appetite. Your response and tolerability guide the plan.
← All treatments
NirvanixInjection
Nx Lean
TirzepatidePackaging may vary. Compounded by a licensed pharmacy, not Nirvanix.
Weight care, with a clear plan
Nx Lean
GLP-1 Weight Loss – Tirzepatide (2.5 mg/week) - 3 Month Supply - Injection
Feel satisfied with less food and make hunger easier to manage, helping you build eating habits that support your weight-loss goals.
Price pending
- Free shipping
Billing details
Shipping: Free. Final total confirmed before payment.
Shipping is included.
State availability is temporarily unavailable. Please check again before starting.
Loading the selected option…
Online enrollment for this option is being prepared. Existing patients can manage their care.
Frequently asked questions
How do the tirzepatide options differ?
The options differ by delivery method and whether NAD+ is part of the proposed care plan. Compare the ingredient and form as well as the name. Injection studies do not establish equivalent results for an oral troche or a combination.
How quickly will my weight change?
There is no fixed response timeline for an individual. The cited study followed specific injectable doses for more than a year; it does not predict results for this preparation. Agree with your clinician on what to track and when to review your response.
Is medication the whole plan?
Your evaluation should also consider nutrition, physical activity, sleep, and other factors affecting your weight and health.
What if I already take a weight-loss medicine?
Share its name, dose, schedule, last dose, and any side effects during the assessment. Your prescriber needs that information before recommending a change; do not overlap or convert treatments on your own.
What if the injection amount or instructions are unclear?
Ask the dispensing pharmacy or prescriber to clarify the exact concentration, amount, and syringe markings before using it. A dose from a different vial or another person's prescription may not match yours.
How do I store and handle my injections?
Use the storage temperature, usable-life date, and handling instructions supplied by your dispensing pharmacy. Concentrations and preparations vary. Ask for clarification before injecting if the label or syringe measurement is unclear.
Safety information & side effects
Tirzepatide has important contraindications and side effects. Review these before starting.
- Do not use with a personal or family history of medullary thyroid cancer, MEN2, or a serious allergy to tirzepatide. Approved tirzepatide carries a boxed warning about thyroid C-cell tumors seen in animals; the risk in humans is unknown.
- Nausea, diarrhea, vomiting, constipation, and abdominal discomfort can occur. Severe or persistent abdominal pain, dehydration, or a serious allergic reaction needs urgent medical assessment.
- Discuss pancreatitis, gallbladder disease, severe stomach-emptying problems, kidney disease, and diabetic eye disease. Insulin and some diabetes medicines can increase low-blood-sugar risk.
- Do not use during pregnancy. Tirzepatide can affect oral contraceptive absorption; discuss additional or non-oral contraception and any planned anesthesia with your clinician. Do not combine with another tirzepatide or GLP-1 medicine unless specifically directed.
- Compounded medicines are not FDA-approved. Their safety, effectiveness, and quality have not been reviewed by FDA. Discuss approved alternatives and the exact preparation with your clinician.
This is a summary, not a complete prescribing guide. Read the information supplied with your prescription. For a severe allergic reaction or another medical emergency, call 911.
Sources & prescribing informationCompare other formulations & protocols
Different strengths, delivery methods, and combinations need their own clinical review.
Clinician reviewedPersonalized careOnline convenience
A closer look
Understand your options.
Start with what this treatment is, why it may be considered, and what to discuss with your clinician.
A once-weekly treatment option
The listed injection schedule can fit into a weekly routine. Use only the amount and instructions prescribed for you.
Progress with a personal plan
Combine treatment decisions with nutrition, movement, and follow-up focused on your health goals.
How it works
Two hormone pathways. One individual decision.
Tirzepatide acts on GIP and GLP-1 receptors involved in glucose regulation and appetite. The strongest weight-loss studies used weekly injections at defined doses. A different delivery method or lower dose needs its own evidence.
Explore the evidenceResearch over time
From appetite research to lasting weight change.
A look at when researchers measured changes with weekly tirzepatide injections, across separate clinical trials.
In a small phase 1 trial of 114 adults without diabetes, the tirzepatide group ate less at a test meal than the placebo group. Researchers also observed lower hunger and appetite scores.
Tirzepatide appetite trial · Nature Medicine, 2025 ↗ (opens in a new tab)Exploratory follow-up in the same trial found lower food-craving scores than placebo. The trial used 5 mg injections for three weeks, then 10 mg; this is not a low-dose treatment forecast.
Tirzepatide appetite trial · Nature Medicine, 2025 ↗ (opens in a new tab)SURMOUNT-4 participants who completed the initial 36 weeks lost 20.9% of their weight on average. This phase used 10 or 15 mg weekly plus lifestyle support, with no placebo comparison.
SURMOUNT-4 · JAMA, 2024 ↗ (opens in a new tab)At week 72 in SURMOUNT-1, average weight reduction was 15% with 5 mg and 20.9% with 15 mg weekly, versus 3.1% with placebo. All groups received lifestyle support; participants did not have diabetes.
SURMOUNT-1 · NEJM, 2022 ↗ (opens in a new tab)At week 88 in SURMOUNT-4, 89.5% who continued tirzepatide kept at least 80% of their initial weight loss, versus 16.6% switched to placebo after week 36. Ongoing treatment was part of that result.
SURMOUNT-4 · JAMA, 2024 ↗ (opens in a new tab)
Month and year labels are approximate; exact study weeks appear in each milestone. These are findings from separate trials, not promised milestones. Study doses, participants, and designs differ. Results do not establish the same outcomes for unspecified low doses, oral troches, compounded preparations, or NAD+ combinations. Treatment suitability, tolerability, and follow-up require individual review.
Personal care starts with context
Is it right for you?
A weight-care assessment looks beyond a number on the scale.
- Your weight-related health conditions and prior treatment experience.
- Your current medicines, digestive symptoms, and history of pancreatitis or gallbladder problems.
- Pregnancy plans and a personal or family history of medullary thyroid cancer or MEN2.
The evidence behind the conversation
Research & guidance.
Know what was studied, who took part, and how it relates to this option. Study findings are not a prediction of your results.
01SURMOUNT-1 · NEJM, 2022
Average weight reduction was 15.0%, 19.5%, and 20.9% with the three studied doses, compared with 3.1% with placebo.
- Treatment studied / guidance scope
- Subcutaneous tirzepatide 5, 10, or 15 mg weekly, with dose escalation and lifestyle support.
- Who it applies to
- 2,539 adults with obesity, or overweight with a weight-related condition, without diabetes.
- Timeframe
- 72 weeks
- Comparison
- Placebo plus lifestyle support
What this means for this optionThese results do not establish outcomes for low-dose regimens, oral troches, compounded preparations, or combinations with NAD+.
Read the source (opens in a new tab)02ZEPBOUND · Prescribing information
Approved injectable tirzepatide acts on GIP and GLP-1 receptors and has important contraindications and route-specific instructions.
- Treatment studied / guidance scope
- FDA-approved subcutaneous tirzepatide.
- Who it applies to
- Adults meeting the labeled indications.
- Timeframe
- Current prescribing information
- Comparison
- Not a trial of this offering
What this means for this optionApproval and dosing instructions for the branded injection do not apply automatically to a compounded preparation, oral troche, or combination.
Read the source (opens in a new tab)How we work
Your next chapter
starts with you.
Tell us about yourself
Choose a treatment and complete its assessment when enrollment is available.
Connect with a clinician
Review your options, including any labs or video visit needed for a decision.
Follow your personal plan
If prescribed, begin treatment and stay connected through your patient portal.
Nirvanix Health
Personal care.
Part of your everyday.
The people behind Nirvanix
Your health deserves a thoughtful conversation.
Our founder, Shane Ali, MD, is a board-certified emergency medicine physician. Meet the Nirvanix team and learn about our approach to care.
Meet the teamYour online clinician is assigned according to your treatment and state.
A little more clarity
Your questions, answered.
Comparing costs or getting ready to start? Read our care FAQs.
Have a question about your own care? Sign in to your account.
How do the tirzepatide options differ?
The options differ by delivery method and whether NAD+ is part of the proposed care plan. Compare the ingredient and form as well as the name. Injection studies do not establish equivalent results for an oral troche or a combination.
How quickly will my weight change?
There is no fixed response timeline for an individual. The cited study followed specific injectable doses for more than a year; it does not predict results for this preparation. Agree with your clinician on what to track and when to review your response.
Is medication the whole plan?
Your evaluation should also consider nutrition, physical activity, sleep, and other factors affecting your weight and health.
What if I already take a weight-loss medicine?
Share its name, dose, schedule, last dose, and any side effects during the assessment. Your prescriber needs that information before recommending a change; do not overlap or convert treatments on your own.
What if the injection amount or instructions are unclear?
Ask the dispensing pharmacy or prescriber to clarify the exact concentration, amount, and syringe markings before using it. A dose from a different vial or another person's prescription may not match yours.
How do I store and handle my injections?
Use the storage temperature, usable-life date, and handling instructions supplied by your dispensing pharmacy. Concentrations and preparations vary. Ask for clarification before injecting if the label or syringe measurement is unclear.
Your goals. Your next chapter.
Let’s make your care personal.
Start with your history and a conversation about what matters to you.
State availability is temporarily unavailable. Please check again before starting.
Prefer an in-person visit? Explore our Austin clinic.